CounterAct PM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Melaleuca, Inc.. The primary component is Diphenhydramine Hydrochloride; Acetaminophen.
| Product ID | 54473-304_7fbf2b51-9097-0a1f-e053-2991aa0a6aa1 |
| NDC | 54473-304 |
| Product Type | Human Otc Drug |
| Proprietary Name | CounterAct PM |
| Generic Name | Acetaminophen And Diphenhydramine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-05-02 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part343 |
| Labeler Name | Melaleuca, Inc. |
| Substance Name | DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN |
| Active Ingredient Strength | 25 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-05-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part343 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-05-02 |
| Marketing Category | OTC monograph not final |
| Application Number | part343 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-05-02 |
| Ingredient | Strength |
|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE | 25 mg/1 |
| SPL SET ID: | 7f9a0062-0e86-1deb-e053-2a91aa0a9188 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 54473-304 | CounterAct | Acetaminophen and Diphenhydramine |
| 59779-577 | CVS | Acetaminophen and Diphenhydramine |
| 63029-049 | Percogesic Extra Strength | Acetaminophen and Diphenhydramine |
| 63029-050 | Percogesic Original Strength | Acetaminophen and Diphenhydramine |